Bone marrow tinctures for cardiovascular disease: lost in translation.
作者信息
Rehman Jalees
出版信息
Circulation. 2013 May 14;127(19):1935-7. doi: 10.1161/CIRCULATIONAHA.113.002775. Epub 2013 Apr 17.
Abstract
摘要
相似文献
1
Bone marrow tinctures for cardiovascular disease: lost in translation.
Circulation. 2013 May 14;127(19):1935-7. doi: 10.1161/CIRCULATIONAHA.113.002775. Epub 2013 Apr 17.
2
Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function.
Circulation. 2013 May 14;127(19):1968-79. doi: 10.1161/CIRCULATIONAHA.112.001035. Epub 2013 Apr 17.
3
[Transepicardial autologous transplantation of bone marrow mononuclear cells for acute myocardial infarction].
Nan Fang Yi Ke Da Xue Xue Bao. 2008 May;28(5):849-51.
4
Long-term effects of bone marrow mononuclear cell transplantation on left ventricular function and remodeling in rats.
Life Sci. 2004 Apr 23;74(23):2853-64. doi: 10.1016/j.lfs.2003.10.035.
5
[Long term follow-up on emergent intracoronary autologous bone marrow mononuclear cell transplantation for acute inferior-wall myocardial infarction].
Zhonghua Yi Xue Za Zhi. 2006 Apr 25;86(16):1107-10.
6
Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network.
Circ Res. 2014 May 9;114(10):1564-8. doi: 10.1161/CIRCRESAHA.114.303720.
7
Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.
Am Heart J. 2006 Sep;152(3):434-41. doi: 10.1016/j.ahj.2006.02.007.
8
Influence of cell treatment with PDGF-BB and reperfusion on cardiac persistence of mononuclear and mesenchymal bone marrow cells after transplantation into acute myocardial infarction in rats.
Cell Transplant. 2009;18(8):847-53. doi: 10.3727/096368909X471134. Epub 2009 Apr 23.
9
Transplantation of bone marrow mononuclear cells does not affect postinfarction electrical remodeling of the heart.
Bull Exp Biol Med. 2008 Jan;145(1):129-32. doi: 10.1007/s10517-008-0029-2.
引用本文的文献
1
Preclinical Studies of Stem Cell Therapy for Heart Disease.
Circ Res. 2018 Mar 30;122(7):1006-1020. doi: 10.1161/CIRCRESAHA.117.312486.
2
Cardiac stem cells: translation to human studies.
Biophys Rev. 2015 Mar;7(1):127-139. doi: 10.1007/s12551-014-0148-0. Epub 2014 Dec 3.
3
Bioenergetic shifts during transitions between stem cell states (2013 Grover Conference series).
Pulm Circ. 2014 Sep;4(3):387-94. doi: 10.1086/677353.
4
Cell therapy for cardiac repair--lessons from clinical trials.
Nat Rev Cardiol. 2014 Apr;11(4):232-46. doi: 10.1038/nrcardio.2014.9. Epub 2014 Mar 4.
5
Multipotent (adult) and pluripotent stem cells for heart regeneration: what are the pros and cons?
Stem Cell Res Ther. 2013 Dec 24;4(6):151. doi: 10.1186/scrt381.
本文引用的文献
1
Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function.
Circulation. 2013 May 14;127(19):1968-79. doi: 10.1161/CIRCULATIONAHA.112.001035. Epub 2013 Apr 17.
2
Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial.
JAMA. 2013 Mar 27;309(12):1241-50. doi: 10.1001/jama.2013.2107.
3
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.
JAMA. 2012 Dec 12;308(22):2380-9. doi: 10.1001/jama.2012.28726.
4
Mixed results for bone marrow–derived cell therapy for ischemic heart disease.
JAMA. 2012 Dec 12;308(22):2405-6. doi: 10.1001/jama.2012.64751.
5
Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis.
Circulation. 2012 Jul 31;126(5):551-68. doi: 10.1161/CIRCULATIONAHA.111.086074. Epub 2012 Jun 22.
6
Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial.
Lancet. 2012 Mar 10;379(9819):895-904. doi: 10.1016/S0140-6736(12)60195-0. Epub 2012 Feb 14.
7
Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.
Lancet. 2011 Nov 26;378(9806):1847-57. doi: 10.1016/S0140-6736(11)61590-0. Epub 2011 Nov 14.
8
In vivo functional and transcriptional profiling of bone marrow stem cells after transplantation into ischemic myocardium.
Arterioscler Thromb Vasc Biol. 2012 Jan;32(1):92-102. doi: 10.1161/ATVBAHA.111.238618. Epub 2011 Oct 27.
9
A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.
J Am Coll Cardiol. 2009 Dec 8;54(24):2277-86. doi: 10.1016/j.jacc.2009.06.055.
10
Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells.
Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1675-82. doi: 10.1152/ajpheart.00665.2008. Epub 2009 Feb 27.
Zotero 插件